Dramatic rise in high blood pressure contributes to many U.S. deaths
the ONA take:
Deaths related to high blood pressure have sharply risen over the last 13 years, according to recent data from the CDC’s National Center for Health Statistics.
In the CDC’s report, hypertension-related deaths was found to have increased by 61.8 percent from 2000 to 2013, and the rate of incidence rose for both sexes aged 45 or older.
The researchers, who pulled their data from national cause-of-death files, counted any mention of hypertension on death certificates as a hypertension-related death.
Overall, one out of six hypertension-related deaths was due to high blood pressure as the underlying cause.
However, the report also found that the proportion of deaths where heart disease was the underlying cause of death had dropped by about 6 percent, while those with stroke as an underlying cause dropped by about 5 percent. High blood pressure was still a contributing factor to other deaths.
Deaths as a result of heart disease, stroke, cancer, and diabetes that mentioned hypertension in certificates made up 65 percent of counted deaths in 2000, and 54 percent of those in 2013.
Deaths related to high blood pressure have sharply risen over the last 13 years.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- No Difference Between RA Seed Localization and Wire Guided Localization
- BRD4 Inhibitor May Enhance Sensitivity to Endocrine Therapies
- Dual HER2 Blockade With an AI Effective in Advanced Breast Cancer
- Loperamide Regimen May Reduce Diarrhea in Neratinib-treated Patients
- PAM50 HER2-E Subtype Predicts pCR Following Lapatinib, Trastuzumab
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|